Literature DB >> 21937704

CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells.

Therese Solstad1, Simer Jit Bains, Johannes Landskron, Einar Martin Aandahl, Bernd Thiede, Kjetil Taskén, Knut Martin Torgersen.   

Abstract

Human CD4(+)FoxP3(+) T cells are functionally and phenotypically heterogeneous providing plasticity to immune activation and regulation. To better understand the functional dynamics within this subset, we first used a combined strategy of subcellular fractionation and proteomics to describe differences at the protein level between highly purified human CD4(+)CD25(+) and CD4(+)CD25(-) T-cell populations. This identified a set of membrane proteins highly expressed on the cell surface of human regulatory T cells (Tregs), including CD71, CD95, CD147, and CD148. CD147 (Basigin or Emmprin) divided CD4(+)CD25(+) cells into distinct subsets. Furthermore, CD147, CD25, FoxP3, and in particular CTLA-4 expression correlated. Phenotypical and functional analyses suggested that CD147 marks the switch between resting (CD45RA(+)) and activated (CD45RO(+)) subsets within the FoxP3(+) T-cell population. Sorting of regulatory T cells into CD147(-) and CD147(+) populations demonstrated that CD147 identifies an activated and highly suppressive CD45RO(+) Treg subset. When analyzing CD4(+) T cells for their cytokine producing potential, CD147 levels grouped the FoxP3(+) subset into 3 categories with different ability to produce IL-2, TNF-α, IFN-γ, and IL-17. Together, this suggests that CD147 is a direct marker for activated Tregs within the CD4(+)FoxP3(+) subset and may provide means to manipulate cells important for immune homeostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937704     DOI: 10.1182/blood-2011-02-339242

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

Review 1.  Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD.

Authors:  Doreen Haase; Mireille Starke; Kia Joo Puan; Tuck Siong Lai; Olaf Rotzschke
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

2.  Depletion of Tregs for adoptive T-cell therapy using CD44 and CD137 as selection markers.

Authors:  Brian G Till; Oliver W Press
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

3.  Immunological monitoring of extracorporeal photopheresis after heart transplantation.

Authors:  M-T Dieterlen; H B Bittner; A Pierzchalski; S Dhein; F W Mohr; M J Barten
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

Review 4.  Function of CD147 in atherosclerosis and atherothrombosis.

Authors:  Cuiping Wang; Rong Jin; Xiaolei Zhu; Jinchuan Yan; Guohong Li
Journal:  J Cardiovasc Transl Res       Date:  2015-01-21       Impact factor: 4.132

Review 5.  T Lymphocytes as Targets for SARS-CoV-2.

Authors:  Elena M Kuklina
Journal:  Biochemistry (Mosc)       Date:  2022-06       Impact factor: 2.824

Review 6.  The plasticity of human Treg and Th17 cells and its role in autoimmunity.

Authors:  Markus Kleinewietfeld; David A Hafler
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

Review 7.  Metabolic reprogramming and metabolic dependency in T cells.

Authors:  Ruoning Wang; Douglas R Green
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 8.  Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Authors:  Julieta Afonso; Lúcio L Santos; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  Nat Rev Urol       Date:  2020-01-17       Impact factor: 14.432

9.  First insight into the kinome of human regulatory T cells.

Authors:  Sebastian König; Michael Probst-Kepper; Tobias Reinl; Andreas Jeron; Jochen Huehn; Burkhart Schraven; Lothar Jänsch
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

10.  IL-2 Expression in Activated Human Memory FOXP3(+) Cells Critically Depends on the Cellular Levels of FOXP3 as Well as of Four Transcription Factors of  T Cell Activation.

Authors:  Hanna Bendfeldt; Manuela Benary; Tobias Scheel; Kerstin Steinbrink; Andreas Radbruch; Hanspeter Herzel; Ria Baumgrass
Journal:  Front Immunol       Date:  2012-08-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.